Search PDMR transactions

Notifier
Name of person with notification obligation
Charles Ballantyne
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Charles Ballantyne
Position
Employee Representative of the Board of Directors or deputy Employee Representative of the Board of Directors
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Ordinary share (HNSA) SE0002148817 Acquisition 25,000 Quantity 2.83414 USD 07/11/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Ordinary share (HNSA) SE0002148817 Acquisition 07/11/2025 Outside a trading venue 25,000 (Quantity) 2.83414 USD
Total: 25,000
<< Back